Enpro Inc. filings document formal disclosures for a New York Stock Exchange-listed industrial technology company. Recent Form 8-K reports cover results of operations and financial condition, including earnings releases, segment performance discussion, adjusted profitability measures and guidance furnished as exhibits.
The company’s proxy and governance filings cover annual meeting matters, director elections, advisory executive compensation votes, board composition and severance-related compensation policies. Other current reports document officer and director changes, shareholder voting results and related corporate governance matters for the North Carolina-incorporated issuer.
Enpro Inc. officer Robert Savage McLean reported a proposed sale of 2,000 common shares, with an aggregate market value of $555,000 and an approximate sale date of February 24, 2026. Charles Schwab & Co., Inc. is named as the broker.
The shares are listed as acquired through restricted stock lapses recorded as equity compensation: 594 shares on February 18, 2022, 933 shares on February 15, 2025, and 473 shares on February 16, 2025.
NPO filed a Form 144 notifying a proposed sale of 5,853 common shares through Fidelity Brokerage Services LLC on 02/23/2026 with an aggregate value shown as $1,607,058.21.
The filing lists multiple prior stock awards by date and award size, which appear as background on the holdings; timing and final sale execution are not stated in the excerpt.
Enpro Inc. presents an annual report outlining its industrial technology portfolio, 2025 performance and key risks. Net sales from continuing operations reached $1,143.3 million, up from $1,048.7 million in 2024, with the semiconductor market providing $367.1 million or 32.1% of sales.
The company operates through Sealing Technologies and Advanced Surface Technologies, serving diverse end markets such as aerospace, commercial vehicles, food and biopharmaceuticals, power generation and life sciences. Enpro completed the acquisitions of Overlook and AlpHa in late 2025 for a combined $273.9 million, and previously bought AMI in early 2024 for $209.4 million, all to strengthen sensing and biopharma capabilities.
Backlog totaled $256.7 million at December 31, 2025, modestly above 2024. The report highlights concentration risk in Advanced Surface Technologies, including one customer representing about 24% of consolidated 2025 net sales, along with detailed risk disclosures on cyclicality, supply chains, cybersecurity, AI use, climate regulation and international operations.
Enpro Inc. reported strong underlying growth for 2025 while absorbing a large, non-cash pension charge. Fourth-quarter sales rose to $295.4 million, up 14.3%, with organic sales up 9.9%. Adjusted EBITDA increased 19.2% to $69.4 million, but GAAP results showed a $32.0 million net loss driven by a $67.2 million non-cash settlement loss from terminating the U.S. defined benefit pension plan.
For the full year 2025, sales reached $1.14 billion, up 9.0%, and adjusted EBITDA grew 8.9% to $277.6 million. Adjusted diluted EPS rose to $7.91 from $6.96, while GAAP diluted EPS declined to $1.91 largely due to the pension settlement. Operating cash flow increased to $201.2 million and free cash flow to $153.1 million, supporting $26.2 million of dividends and an eleventh consecutive annual dividend increase.
Management introduced 2026 guidance calling for revenue growth of 8%–12%, adjusted EBITDA of $305–$320 million, and adjusted diluted EPS of $8.50–$9.20, reflecting confidence in demand across Sealing Technologies and Advanced Surface Technologies and the benefits of a strengthened balance sheet.
Enpro Inc.'s President and CEO Eric A. Vaillancourt reported equity award activity and related tax withholding transactions. On 02/16/2026 he acquired 13,418 shares of common stock as a grant at $0.0000 per share, increasing his direct holdings to 54,744 shares.
On 02/15/2026 and 02/16/2026, restricted stock units were exercised into 3,211 and 4,011 common shares, respectively, at no cost. To cover tax liabilities, 1,320 shares and 7,480 shares of common stock were disposed of at $272.63 per share through share withholding, leaving 51,275 shares held directly and 2,997 shares held indirectly via a 401(k) plan.
McLean Robert Savage reported multiple insider transaction types in a Form 4 filing for NPO. The filing lists transactions totaling 6,851 shares at a weighted average price of $272.63 per share. Following the reported transactions, holdings were 32,430 shares.
Enpro Inc. executive Larisa R. Joiner reported multiple equity transactions involving company stock. On 02/15/2026 and 02/16/2026, she exercised restricted stock units into common shares at an exercise price of $0, and some of the resulting shares were withheld at $272.63 per share to cover tax obligations. She also received a grant or award of 854 common shares at no cost. Following these transactions, she directly owned 9,431 shares of Enpro common stock.
Enpro Inc. executive Steven R. Bower, SVP, Controller and CAO, reported multiple equity compensation transactions in Enpro common stock. On 02/15/2026 and 02/16/2026, restricted stock units were exercised into common shares at an exercise price of $0, and new common shares were granted at $0.0000 per share.
To cover tax obligations, Bower disposed of common shares through tax-withholding transactions at $272.63 per share. After these activities, he held 3,651 common shares directly and 6,428 common shares indirectly through an IRA, along with 218 restricted stock units that remain outstanding.
Bruderek Joseph F Jr. reported multiple insider transaction types in a Form 4 filing for NPO. The filing lists transactions totaling 1,408 shares at a weighted average price of $272.63 per share. Following the reported transactions, holdings were 618 shares.
Bianchi Amy reported acquisition or exercise transactions in this Form 4 filing.
Enpro Inc. executive vice president and chief human resources officer Amy Bianchi reported an equity compensation award in the form of 859 restricted stock units on February 12, 2026. Each unit represents a right to receive one share of Enpro common stock plus cash equal to dividends paid since the grant date.
The 859 restricted stock units vest in approximately equal thirds on February 12, 2027, February 12, 2028, and February 12, 2029, subject to continued employment. Following this grant, Bianchi directly holds 859 derivative securities linked to Enpro common stock.